Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects
Clinical trial NCT01177540 · TERMINATED
Trial details
- NCT number
- NCT01177540
- Sponsor
- Eisai Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-03
- Primary completion
- 2013-07-19
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.